Olympus Corporation
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Olympus Corporation Olympus Corporation (OCPNY) is a leading global MedTech company that develops, manufactures and markets precision medical devices focused on endoscopy-enabled care, including endoscopes, laparoscopes, video imaging systems, endotherapy devices, therapeutic energy devices, surgical energy systems and system integration solutions for diagnostic, therapeutic and minimally invasive procedures; the company serves healthcare professionals worldwide with solutions for gastroenterology, urology, respiratory, ear-nose-throat (ENT), gynecology and other specialties to improve clinical outcomes, reduce costs and enhance patient quality of life. Headquartered in Shinjuku-ku, Tokyo, Japan, and founded in 1919 as Takachiho Seisakusho, Olympus Corporation operates in nearly 40 countries and regions with approximately 29,000 employees, maintaining a dominant approximately 70% share of the global endoscope market valued at around $2.5 billion; its operations span Japan, the Americas, Europe, the Middle East, Asia and Oceania, targeting hospitals, clinics, academic institutions and surgical centers. In recent developments, the company unveiled a new corporate strategy in November 2025 emphasizing innovation-driven growth, operational simplicity and accountability to advance endoscopy-enabled care through intelligent integrated solutions and margin expansion; it expanded strategic partnerships including a preferred collaboration with Proximie for telecollaboration platforms in the U.S. and Canada in October 2024, an extension with HCLTech for AI-enabled engineering and R&D establishing a dedicated innovation center in India in 2024, and distribution agreements with W.L. Gore & Associates for EndoTherapy expansion, MacroLux Medical for single-use urology products and others; Olympus also launched the OLYSENSE platform with CADe/AI capabilities in the U.S. in September 2025, introduced new imaging platforms for ENT and urology, announced respiratory business leadership appointments and entered a build-to-buy agreement potentially worth up to $458 million for Swan EndoSurgical's robotic endoluminal platform in late 2025, while noting prior divestitures of its camera, life science and industrial solutions businesses to OM Digital Solutions and Evident Corporation.
Mercury Insurance and Olympus Insurance Partner to Expand Auto and Home Bundling in Florida and Unlock New Savings
Olympus (OTCMKTS:OCPNY) Stock Price Passes Above 50 Day Moving Average – Should You Sell?
Olympus (OTCMKTS:OCPNY) Stock Price Crosses Above Fifty Day Moving Average – Here’s What Happened
Olympus Corporation (OLYMY) Q3 2026 Earnings Call Transcript
Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Olympus (OTCMKTS:OCPNY) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?
Olympus Corporation (OLYMY) Discusses New Strategic Vision and Expansion of Endoscopy-Enabled Care Prepared Remarks Transcript
Olympus Corporation (OLYMY) Q1 2026 Earnings Call Transcript
Trends Shaping Qatar's Infection Control Market 2025-2034: Featuring Sidra Medicine, BD, Condair, Sotera Health, Olympus, 3M
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf
Apollo Announces Olympus Housing Capital
Olympus Corporation (OLYMY) Q4 2025 Earnings Call Transcript
Olympian Motors and Foxconn Partner to Launch Olympus OS: AI-Defined Vehicle Operating System
Monroe Capital Supports Olympus Partners' Acquisition of PAI Pharma
Monroe Capital Supports Olympus Partners' Acquisition of Accelevation Holding Company, LLC
Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript
Olympus Corporation (OLYMY) Q2 2025 Earnings Call Transcript
Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility
Olympus Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available